738 related articles for article (PubMed ID: 10678385)
1. Preliminary experience with Silzone-coated St. Jude medical valves in acute infective endocarditis.
Bertrand S; Houel R; Vermes E; Soustelle C; Hillion ML; Loisance D
J Heart Valve Dis; 2000 Jan; 9(1):131-4. PubMed ID: 10678385
[TBL] [Abstract][Full Text] [Related]
2. First clinical experience with a mechanical valve with silver coating.
Brutel de la Riviere A; Dossche KM; Birnbaum DE; Hacker R
J Heart Valve Dis; 2000 Jan; 9(1):123-9; discussion 129-30. PubMed ID: 10678384
[TBL] [Abstract][Full Text] [Related]
3. Definitive cure of recurrent prosthetic endocarditis using silver-coated St. Jude Medical heart valves: a preliminary case report.
Carrel T; Nguyen T; Kipfer B; Althaus U
J Heart Valve Dis; 1998 Sep; 7(5):531-3. PubMed ID: 9793852
[TBL] [Abstract][Full Text] [Related]
4. Seven-year results with the St Jude Medical Silzone mechanical prosthesis.
Jamieson WR; Fradet GJ; Abel JG; Janusz MT; Lichtenstein SV; MacNab JS; Stanford EA; Chan F
J Thorac Cardiovasc Surg; 2009 May; 137(5):1109-15.e2. PubMed ID: 19379975
[TBL] [Abstract][Full Text] [Related]
5. Silzone-coated St. Jude Medical valves: six-year experience in 46 patients.
Dandekar UP; Baghai M; Kalkat M; Ridley PD
J Heart Valve Dis; 2007 Jan; 16(1):37-41. PubMed ID: 17315381
[TBL] [Abstract][Full Text] [Related]
6. Prosthetic heart valves with silver-coated sewing cuff fabric: early morphological features in two patients.
Butany J; Scully HE; VanArsdell G; Leask R
Can J Cardiol; 2002 Jul; 18(7):733-8. PubMed ID: 12167960
[TBL] [Abstract][Full Text] [Related]
7. [Surgical interventions for complex native valve endocarditis].
Wang ZN; Zhang BR; Xu ZY; Hao JH; Zou LJ; Mei J; Xu JB
Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):657-60. PubMed ID: 15329253
[TBL] [Abstract][Full Text] [Related]
8. Time-related risk of the St. Jude Silzone heart valve.
Grunkemeier GL; Jin R; Im K; Holubkov R; Kennard ED; Schaff HV
Eur J Cardiothorac Surg; 2006 Jul; 30(1):20-7. PubMed ID: 16730188
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment of infective mitral valve endocarditis: predictors of early and late outcome.
Alexiou C; Langley SM; Stafford H; Haw MP; Livesey SA; Monro JL
J Heart Valve Dis; 2000 May; 9(3):327-34. PubMed ID: 10888086
[TBL] [Abstract][Full Text] [Related]
10. Pathologic analysis of 19 heart valves with silver-coated sewing rings.
Butany J; Leask RL; Desai ND; Jegatheeswaran A; Silversides C; Scully HE; Feindel C
J Card Surg; 2006; 21(6):530-8. PubMed ID: 17073948
[TBL] [Abstract][Full Text] [Related]
11. Surgical results for active endocarditis with prosthetic valve replacement: impact of culture-negative endocarditis on early and late outcomes.
Murashita T; Sugiki H; Kamikubo Y; Yasuda K
Eur J Cardiothorac Surg; 2004 Dec; 26(6):1104-11. PubMed ID: 15541970
[TBL] [Abstract][Full Text] [Related]
12. [Late complications following Björk-Shiley and St. Jude Medical heart valve replacement].
Horstkotte D; Körfer R; Budde T; Haerten K; Schulte HD; Bircks W; Loogen F
Z Kardiol; 1983 May; 72(5):251-61. PubMed ID: 6880335
[TBL] [Abstract][Full Text] [Related]
13. Importance of implant technique on risk of major paravalvular leak (PVL) after St. Jude mechanical heart valve replacement: a report from the Artificial Valve Endocarditis Reduction Trial (AVERT).
Englberger L; Schaff HV; Jamieson WR; Kennard ED; Im KA; Holubkov R; Carrel TP;
Eur J Cardiothorac Surg; 2005 Dec; 28(6):838-43. PubMed ID: 16275007
[TBL] [Abstract][Full Text] [Related]
14. [Surgical correction with homograft in native or prosthetic aortic valve infective endocarditis].
Gamba A; Terzi A; Ferrazzi P; Farina C; Suter F
Ital Heart J Suppl; 2002 Jul; 3(7):728-37. PubMed ID: 12187633
[TBL] [Abstract][Full Text] [Related]
15. Aortic root abscess and secondary infective mitral valve disease: results of surgical endocarditis treatment.
Siniawski H; Grauhan O; Hofmann M; Pasic M; Weng Y; Yankah C; Lehmkuhl H; Hetzer R
Eur J Cardiothorac Surg; 2005 Mar; 27(3):434-40. PubMed ID: 15740952
[TBL] [Abstract][Full Text] [Related]
16. Early outcome after surgery for active native and prosthetic aortic valve endocarditis.
Gabbieri D; Dohmen PM; Linneweber J; Grubitzsch H; von Heymann C; Neumann K; Halle E; Konertz WF
J Heart Valve Dis; 2008 Sep; 17(5):508-24; discussion 525. PubMed ID: 18980085
[TBL] [Abstract][Full Text] [Related]
17. Mid-term follow up of mitral valve reconstruction due to active infective endocarditis.
Podesser BK; Rödler S; Hahn R; Eigenbauer E; Vodrazka M; Moritz A; Laufer G; Simon P; Wolner E
J Heart Valve Dis; 2000 May; 9(3):335-40. PubMed ID: 10888087
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of double valve surgery for active infective endocarditis.
Sheikh AM; Elhenawy AM; Maganti M; Armstrong S; David TE; Feindel CM
J Thorac Cardiovasc Surg; 2009 Jul; 138(1):69-75. PubMed ID: 19577059
[TBL] [Abstract][Full Text] [Related]
19. Native versus primary prosthetic valve endocarditis: comparison of clinical features and long-term outcome in 353 patients.
Romano G; Carozza A; Della Corte A; De Santo LS; Amarelli C; Torella M; De Feo M; Cerasuolo F; Cotrufo M
J Heart Valve Dis; 2004 Mar; 13(2):200-8; discussion 208-9. PubMed ID: 15086258
[TBL] [Abstract][Full Text] [Related]
20. Surgical treatments for infective endocarditis involving valve annulus.
Ishikawa S; Kawasaki A; Neya K; Abe K; Suzuki H; Koizumi S; Shibuya H; Horikawa M; Ueda K
Ann Thorac Cardiovasc Surg; 2009 Dec; 15(6):378-81. PubMed ID: 20081746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
